Christopher Ware Sells 189 Shares of Itron (NASDAQ:ITRI) Stock

Posted by Geri Gentry on May 23rd, 2026

Itron, Inc. (NASDAQ:ITRI – Get Free Report) SVP Christopher Ware sold 189 shares of the business’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $79.60, for a total transaction of $15,044.40. Following the completion of the sale, the senior vice president directly owned 30,506 shares of the company’s stock, valued at approximately $2,428,277.60. The trade was a 0.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Trading Up 1.4%

Shares of Itron stock opened at $83.02 on Friday. The firm has a 50-day moving average of $88.45 and a 200-day moving average of $94.52. The stock has a market cap of $3.68 billion, a PE ratio of 13.24, a PEG ratio of 0.72 and a beta of 1.35. Itron, Inc. has a 52-week low of $77.77 and a 52-week high of $142.00. The company has a debt-to-equity ratio of 0.97, a quick ratio of 2.24 and a current ratio of 2.66.

Itron (NASDAQ:ITRI – Get Free Report) last announced its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.23. The company had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. Itron’s quarterly revenue was down 3.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, sell-side analysts forecast that Itron, Inc. will post 6.01 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ITRI. Impax Asset Management Group plc raised its stake in Itron by 127.3% in the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after purchasing an additional 890,040 shares in the last quarter. Norges Bank bought a new position in Itron in the fourth quarter valued at about $63,990,000. Soros Fund Management LLC bought a new position in Itron in the fourth quarter valued at about $34,843,000. Millennium Management LLC grew its position in Itron by 269.3% in the fourth quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock valued at $47,068,000 after acquiring an additional 369,617 shares during the last quarter. Finally, Merewether Investment Management LP grew its position in Itron by 1,552.7% in the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock valued at $39,593,000 after acquiring an additional 282,587 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Key Headlines Impacting Itron

Here are the key news stories impacting Itron this week:

Positive Sentiment: Stephens reiterated an Overweight rating on Itron and kept a $130 price target, signaling substantial upside versus recent trading levels.
Neutral Sentiment: Several Itron executives sold small amounts of stock, but the filings say the shares were sold mainly to cover tax withholding tied to equity award vesting, which makes the insider activity look routine rather than a major red flag.
Negative Sentiment: Zacks Research cut multiple future earnings estimates for Itron, including a sharp reduction to Q4 2027 EPS and a lower FY2027 outlook, suggesting softer profit growth ahead.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ITRI. Guggenheim set a $155.00 price target on Itron in a research note on Friday, February 13th. Zacks Research raised Itron from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 26th. Raymond James Financial began coverage on Itron in a research note on Tuesday, April 21st. They issued an “underperform” rating for the company. Needham & Company LLC began coverage on Itron in a research note on Friday, March 6th. They issued a “buy” rating and a $124.00 price target for the company. Finally, Robert W. Baird set a $128.00 price target on Itron and gave the company an “outperform” rating in a research note on Wednesday, February 18th. Eight equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $131.22.

Get Our Latest Research Report on Itron

About Itron

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.